Internal Medicine, San Giovanni di Dio Hospital, Via di Torregalli 3, 50143 Firenze, Italy.
Internal Medicine, San Giovanni di Dio Hospital, Via di Torregalli 3, 50143 Firenze, Italy.
Eur J Intern Med. 2021 Mar;85:92-97. doi: 10.1016/j.ejim.2020.12.025. Epub 2021 Jan 12.
Few data are available on the validity of "Sepsis-3" criteria in identifying patients with sepsis in internal medicine wards (IMWs). Real-life data about this topic and on the prevalence of sepsis in IMWs could be useful for improving hospital organization.
To assess the validity of "Sepsis-3" criteria in identifying patients with community-onset sepsis in IMWs. Secondary objectives: to evaluate the prevalence of these patients in IMWs and to compare "Sepsis-3" and "Sepsis-1" criteria.
Multicenter, prospective, observational, cohort study, carried out in 22 IMWs of Tuscany (Italy). All patients admitted to each of the study centers over a period of 21-31 days were evaluated within 48 hours; those with clinical signs of infection were enrolled. The main outcome was in-hospital mortality.
2,839 patients were evaluated and 938 (33%) met the inclusion criteria. Patients with sepsis diagnosed according to "Sepsis-3" were 522, representing 55.6% of patients with infection and 18.4% of all patients hospitalized; they were older than those without sepsis (79.4±12.5 vs 74.6±15.2 years, p<0.001). In-hospital mortality was significantly higher in patients with sepsis compared to others (13.8% vs 4.6%; p<0.001). "Sepsis-3" criteria showed greater predictive validity for in-hospital mortality than "Sepsis-1" criteria (AUROC=0.71; 95%CI, 0.66-0.77 vs 0.60; 95%CI 0.54-0.66; p=0.0038).
"Sepsis-3" criteria are able to identify patients with community-onset sepsis in IMWs, whose prevalence and in-hospital mortality are remarkably high. Medical departments should adapt their organization to the needs for care of these complex patients.
关于“Sepsis-3”标准在确定内科病房(IMW)中脓毒症患者方面的有效性,相关数据较少。关于这一主题和 IMW 中脓毒症患病率的实际数据,对于改善医院组织可能会有所帮助。
评估“Sepsis-3”标准在确定 IMW 中社区获得性脓毒症患者中的有效性。次要目标:评估这些患者在 IMW 中的患病率,并比较“Sepsis-3”和“Sepsis-1”标准。
这是一项多中心、前瞻性、观察性队列研究,在意大利托斯卡纳的 22 个 IMW 中进行。在 21-31 天的时间段内,对每个研究中心入院的所有患者在 48 小时内进行评估;有感染临床迹象的患者被纳入研究。主要结局是院内死亡率。
共评估了 2839 名患者,其中 938 名(33%)符合纳入标准。根据“Sepsis-3”诊断为脓毒症的患者有 522 例,占感染患者的 55.6%,占所有住院患者的 18.4%;他们比没有脓毒症的患者年龄更大(79.4±12.5 岁 vs 74.6±15.2 岁,p<0.001)。与其他患者相比,脓毒症患者的院内死亡率明显更高(13.8% vs 4.6%;p<0.001)。“Sepsis-3”标准对院内死亡率的预测有效性大于“Sepsis-1”标准(AUROC=0.71;95%CI,0.66-0.77 与 0.60;95%CI 0.54-0.66;p=0.0038)。
“Sepsis-3”标准能够识别 IMW 中社区获得性脓毒症患者,其患病率和院内死亡率非常高。医疗部门应根据这些复杂患者的护理需求调整其组织。